Entries by

,

EVEON is accelerating its development for the benefit of pharmaceutical companies and patient treatment adherence

Grenoble, March 8, 2022 – EVEON, designer and manufacturer of medical devices for the preparation and delivery of drugs, made numerous project achievements in 2021 in collaboration with pharmaceutical companies. It looks like another promising year ahead for the company as it is carried forward by its dynamism and its innovations for better therapeutic compliance. […]

,

IMABGEN Project, an innovative platform in immunotherapies

Lyon, December 16, 2021 The IMABGEN Platform project, an innovative service for the generation of therapeutic antibodies carried by BIOTEM, CALIXAR and the CNRS / Université Claude Bernard Lyon 1, is one of the laureates of the ‘‘R&D Booster’’ 2021 program driven by the Region Auvergne-Rhône-Alpes. Immunotherapy has become a major approach in the fight […]

,

Microlight3D marks fifth anniversary and reinforces team

Company keeps pace with increased sales and deliveries of new 3D microprinting equipment with recruitment in development, manufacturing and sales Grenoble, France, December 2, 2021 – Microlight3D, a specialty manufacturer of high-resolution micro-scale 2D & 3D printing systems for industrial and scientific applications, today celebrates its fifth anniversary and the arrival of five new team […]

,

ALPAO, selected for the French space recovery plan, as part of a consortium led by Airbus Defence & Space

Grenoble (France) – November 15, 2021 – ALPAO, selected for a prestigious consortium to contribute to the development of the space industry as part of the French recovery plan, is strengthening its leadership position in adaptive optics. One of these collaborative projects aims to structure the French industrial sector for satellite laser communications. The purpose […]

,

NH TherAguix announces the release of a new clinical batch for its drug AGuIX, manufactured by CARBOGEN AMCIS

MEYLAN, France, BUBENDORF, Switzerland, (November 3rd, 2021) – NH TherAguix, a clinical stage company developing innovative nanomedicine for the treatment of cancer, and CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and Drug Products manufacturing company, announced today the release of a new batch of AGuIX Drug Product for clinical trials. CARBOGEN […]

,

Cell-free expressed OprF proteoliposomes as effective vaccine against Pseudomonas aeruginosa ?

Synthelis’ cell-free liposome-based expression system was applied in the development of an OprF vaccine against Pseudomonas aeruginosa. The complete OprF outer membrane protein of P. aeruginosa was used as the immunogen and was expressed in its native form in liposomes. The resulting OprF proteoliposomes were fully characterized and their ability to induce an immunogenic response in mice was tested. The […]

,

Vulkalloy®Zr Med, a “Medical” Metal Alloy An innovative microsurgery forceps design

              Context and challenges in the design of microsurgical instruments The design of microsurgical and endoscopic instruments is currently confronted with a limit to the characteristics of the materials and implementation solutions proposed. The trend in user demand is towards greater quality and precision and that of health service […]

,

NH TherAguix staff member awarded with a Ph.D. prize

  NH TherAguix (“NHT”) is pleased to announce that Fabien Boux was awarded with the Ph. D. prize 2020 of the Société Française de Résonance Magnétique en Biologie et Médecine (“SFRMBM”). Fabien Boux joined the Clinical Development Unit of NHT team in January 2021  as a Biomedical Engineer. He is in charge of the design and […]

,

LXRepair receives €750,000 in funding from BPI France as part of the DeepTech program

Grenoble, July 8th, 2021 – LXRepair, a biotechnology start-up specializing in personalized medicine testing, today announces the granting of €750,000 in funding under the BPI France DeepTech program. This program supports advanced and highly differentiating biotechnology projects with significant commercial potential. This is the case of LXRepair: predicting serious late side effects is the “Holy […]

,

BEPATIENT x EVEON: Smart integration

Smart medical device designer and manufacturer, EVEON,  and virtual trials & digital therapeutics platform, BEPATIENT, announce an exciting new strategic partnership. Paris and Grenoble (France), 18th May, 2021 – BEPATIENT, a pioneer in the development of virtual trials and digital therapeutics solutions, has signed a collaboration agreement with EVEON, designer and manufacturer of smart medical […]